Overview
The Endo One dual-wavelength diode laser (980/1470 nm) has emerged as a valuable tool for providers treating the jawline, submental region, and neck. By combining two wavelengths in one system, the device addresses both fat reduction and tissue tightening:
980 nm selectively targets and emulsifies adipocytes, making it effective for reducing submental fat and redefining the Cervicofacial angle.
1470 nm penetrates water-rich tissues, inducing controlled subdermal heating, collagen denaturation, and subsequent neocollagenesis for progressive skin tightening.
For providers, this translates into a procedure that can:
Improve jawline contour and neck definition in patients with mild-to-moderate laxity.
Offer results superior to surface-based technologies, thanks to its subdermal precision.
Complement other modalities, such as threads, fillers, or RF microneedling, for a comprehensive rejuvenation protocol.
Clinical experience demonstrates that results continue to improve for 6–12 months as collagen remodeling occurs. Most patients appreciate the balance between noticeable results and minimal downtime, making the procedure highly marketable.
For practices, the Endo One represents an opportunity to expand their non-surgical portfolio while meeting the growing demand for natural, subtle facial rejuvenation.
Key Takeaways for Providers
Dual Action in One Procedure: 980 nm wavelength for submental/jowl fat reduction and 1470 nm for collagen remodeling and tightening.
High Patient Demand: Appeals to patients seeking natural contouring results without surgery, particularly in the jawline and neck.
Practice Growth Opportunity: Expands your non-surgical treatment portfolio with a procedure that combines visible results, minimal downtime, and high satisfaction.